Video Library

Dr. Theresa Callard-Moore discusses how cancer treatment and transplant can affect sexual health, intimacy, and relationships. She covers common physical and emotional challenges and offers practical strategies for communication, rebuilding intimacy, managing discomfort, and getting support from the healthcare team.

This presentation reviews the latest advances in preventing and treating acute and chronic graft-versus-host disease (GVHD). Dr. Cutler discusses how post-transplant cyclophosphamide (PTCy) has changed GVHD prevention, new treatments for chronic GVHD, and research on combination therapies and early intervention. He also answers questions about clinical trials, treatment duration, and GVHD’s relationship to relapse.

Graft-versus-host disease (GVHD) is a potential complication after a bone marrow/stem cell transplant using donor cells. This presentation explains what GVHD (GVHD) is, the difference between acute and chronic GVHD, risk factors for developing GVHD, how to monitor yourself to catch and report symptoms early, treatment options, and lifestyle changes that can improve GVHD symptoms.

In this session, leading experts on graft-versus-host disease (GVHD), a common complication after a bone marrow/stem cell transplant, respond to questions about who is at risk of developing GVHD, symptoms of GVHD, and how to manage both the physical and emotional problems associated with GVHD and its treatment.

Graft-versus-host-disease (GVHD) can be a significant problem after stem cell transplantation. This presentation discusses what GVHD is, risk factors for developing it and recent advances in the prevention and treatment of GVHD.

Graft-versus-host-disease (GVHD) can be a major complication after bone marrow/stem cell transplantation. This presentation describes the types of GVHD, its typical effects on patients, and several promising new treatments for this condition.

Graft versus Host Disease (GVHD) is a common complication after allogeneic stem cell transplant. Learn the difference between acute and chronic GVHD and how each develops. Both standard therapies and exciting new prevention and treatment interventions are discussed.

Graft-versus-host disease (GVHD) is a common complication after a bone marrow/stem cell transplant using donor cells (allogeneic transplant). This presentation will discuss current techniques to prevent GVHD, new drugs to treat acute and chronic GVHD and clinical trials testing new GVHD therapies.

The overall health of the gut microbiome and its organisms can influence the prevalence and severity of graft-versus-host disease. This presentation reviews the causes and mechanisms of how organisms in the gut can affect GVHD and reviews potential strategies to minimize this problem.

Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant. Extracorporeal photopheresis (ECP) can be an effective treatment for certain types of GVHD. This presentation explains how ECP works and its potential benefits for patients with significant GVHD.

Graft-versus-host-disease (GVHD) is a common challenge for patients who undergo a stem cell transplant using cells from a donor (an allogeneic transplant). It can be mild, moderate or severe. This presentation reviews the types of GVHD, the organs most often affected, common symptoms, and traditional as well as newer therapies for treating GVHD.

La Enfermedad de Injerto contra Huésped (EICH) puede ser aguda o crónica. Este taller explica la diferencia entre ambas, los factores de riesgo, su incidencia, cuáles son los síntomas, cuándo comienzan y cuánto duran. También explica las terapias para el tratamiento de la EICH aguda y crónica, así como los efectos secundarios de esos medicamentos.